NCT00400283View on ClinicalTrials.gov

A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

January 19, 2001

Primary Completion Date

May 3, 2001

Study Completion Date

May 3, 2001

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

NNC 55-0414

Trial Locations (1)

14050

Novo Nordisk Investigational Site, Berlin

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY